2-Nitro-1-(4-methylsulfon-phenyl)-propen-(1) | 15452-52-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-Nitro-1-(4-methylsulfon-phenyl)-propen-(1)
• 英文别名: 1-methanesulfonyl-4-(2-nitro-propenyl)-benzene；1-Methylsulfonyl-4-(2-nitroprop-1-enyl)benzene
• CAS: 15452-52-5
• 化学式: C₁₀H₁₁NO₄S
• 分子量: 241.268
• InChiKey: KYNRPCVREMUPNG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  88.3
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-Nitro-1-(4-methylsulfon-phenyl)-propen-(1) 在 溴 、 铁粉 、 溶剂黄146 作用下， 以 1,4-二氧六环 、 乙醇 为溶剂， 生成 5-(4-methanesulfonyl-phenyl)-4-methyl-thiazol-2-ylamine
  参考文献：
  名称：

  Development of isoform selective PI3-kinase inhibitors as pharmacological tools for elucidating the PI3K pathway

  摘要：

  Using a parallel synthesis approach to target a non-conserved region of the PI3K catalytic domain a pan-PI3K inhibitor 1 was elaborated to provide alpha, delta and gamma isoform selective Class I PI3K inhibitors 21, 24, 26 and 27. The compounds had good cellular activity and were selective against protein kinases and other members of the PI3K superfamily including mTOR and DNA-PK. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.07.042
• 作为产物：
  描述：

  对氟苯甲醛 在 ammonium acetate 作用下， 以 二甲基亚砜 为溶剂， 生成 2-Nitro-1-(4-methylsulfon-phenyl)-propen-(1)
  参考文献：
  名称：

  Development of isoform selective PI3-kinase inhibitors as pharmacological tools for elucidating the PI3K pathway

  摘要：

  Using a parallel synthesis approach to target a non-conserved region of the PI3K catalytic domain a pan-PI3K inhibitor 1 was elaborated to provide alpha, delta and gamma isoform selective Class I PI3K inhibitors 21, 24, 26 and 27. The compounds had good cellular activity and were selective against protein kinases and other members of the PI3K superfamily including mTOR and DNA-PK. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.07.042

文献信息

• Iridium-catalyzed highly chemoselective and efficient reduction of nitroalkenes to nitroalkanes in water
  作者：Dong Xu、Yang Chen、Changmeng Liu、Jiaxi Xu、Zhanhui Yang

  DOI：10.1039/d1gc01907d

  日期：——

  An iridium-catalyzed highly chemoselective and efficient transfer hydrogenation reduction of structurally diverse nitroalkenes was realized at very low catalyst loading (S/C = up to 10000 or 20 000), using formic acid or sodium formate as a traceless hydride donor in water. Excellent functionality tolerance is also observed. The turnover number and turnover frequency of the catalyst reach as high as

  在非常低的催化剂负载量（S/C = 高达 10000 或 20 000）下，使用甲酸或甲酸钠作为水中的无痕氢化物供体，实现了铱催化的高化学选择性和高效转移氢化还原结构多样的硝基烯烃。还观察到优异的功能耐受性。催化剂的周转次数和周转频率高达18 600和19 200 h -1， 分别。不需要惰性气氛保护。硝基烯烃的反应性取决于它们的取代模式，pH 值是实现完全转化和优异化学选择性的关键因素。产品的纯化通过简单的萃取实现，无需柱层析。还原过程在 10 000 S/C 比率下轻松放大到 10 g 规模。这种绿色还原在对映选择性氢化中的潜力已经得到证实。
• Iridium-Catalyzed and pH-Dependent Reductions of Nitroalkenes to Ketones
  作者：Tingting Wang、Changmeng Liu、Dong Xu、Jiaxi Xu、Zhanhui Yang

  DOI：10.3390/molecules27227822

  日期：——

  A highly chemoselective conversion of α,β-disubstituted nitroalkenes to ketones is developed. An acid-compatible iridium catalyst serves as the key to the conversion. At a 2500 S/C ratio, nitroalkenes were readily converted to ketones in up to 72% isolated yields. A new mechanistic mode involving the reduction of nitroalkene to nitrosoalkene and N-alkenyl hydroxylamine is proposed. This conversion

  开发了α,β-二取代硝基烯烃向酮的高度化学选择性转化。与酸相容的铱催化剂是转化的关键。在 2500 S/C比率下，硝基烯烃很容易转化为酮，分离产率高达 72%。提出了一种新的机制模式，涉及将硝基烯烃还原为亚硝基烯烃和N -烯基羟胺。这种转化已准备好放大到克级合成。pH值在控制化学选择性方面起着不可或缺的作用。
• WO2008/52733
  申请人：——

  公开号：——

  公开（公告）日：——
• Anorexigenic Agents: Aromatic Substituted 1-Phenyl-2-propylamines
  作者：Gerald F. Holland、Carl J. Buck、Albert Weissman

  DOI：10.1021/jm00341a011

  日期：1963.9
• Development of isoform selective PI3-kinase inhibitors as pharmacological tools for elucidating the PI3K pathway
  作者：Ian Bruce、Mohammed Akhlaq、Graham C. Bloomfield、Emma Budd、Brian Cox、Bernard Cuenoud、Peter Finan、Peter Gedeck、Julia Hatto、Judy F. Hayler、Denise Head、Thomas Keller、Louise Kirman、Catherine Leblanc、Darren Le Grand、Clive McCarthy、Desmond O’Connor、Charles Owen、Mrinalini S. Oza、Gaynor Pilgrim、Nicola E. Press、Lilya Sviridenko、Lewis Whitehead

  DOI：10.1016/j.bmcl.2012.07.042

  日期：2012.9

  Using a parallel synthesis approach to target a non-conserved region of the PI3K catalytic domain a pan-PI3K inhibitor 1 was elaborated to provide alpha, delta and gamma isoform selective Class I PI3K inhibitors 21, 24, 26 and 27. The compounds had good cellular activity and were selective against protein kinases and other members of the PI3K superfamily including mTOR and DNA-PK. (C) 2012 Elsevier Ltd. All rights reserved.